Clinical utility of daylight photodynamic therapy in the treatment of actinic keratosis – a review of the literature

References

• Berman B, Cockerell CJ. Pathobiology of actinic keratosis: ultraviolet-dependent keratinocyte proliferation. J Am Acad Dermatol. 2013;68(1 Suppl 1):S10–S19. doi:10.1016/j.jaad.2012.09.05323228301
   PubMed Web of Science ®Google Scholar
• Costa C, Scalvenzi M, Ayala F, Fabbrocini G, Monfrecola G. How to treat actinic keratosis? An update. J Dermatol Case Rep. 2015;9(2):29–35. doi:10.3315/jdcr.2015.119926236409
   PubMed Web of Science ®Google Scholar
• Lee PK, Kloser A. Current methods for photodynamic therapy in the US: comparison of MAL/PDT and ALA/PDT. J Drugs Dermatol. 2013;12(8):925–930.23986167
   PubMed Web of Science ®Google Scholar
• Cohen DK, Lee PK. Photodynamic therapy for non-melanoma skin cancers. Cancers (Basel). 2016;8(10). doi:10.3390/cancers8100090
   Web of Science ®Google Scholar
• Morton CA, Braathen LR. Daylight photodynamic therapy for actinic keratoses. Am J Clin Dermatol. 2018;19:647–656. doi:10.1007/s40257-018-0360-y29752702
   PubMed Web of Science ®Google Scholar
• Ericson MB, Wennberg A-M, Larkö O. Review of photodynamic therapy in actinic keratosis and basal cell carcinoma. Ther Clin Risk Manag. 2008;4(1):1–9.18728698
   PubMedGoogle Scholar
• Palm M, Goldman MP. Aminolevulinic acid: actinic keratosis and photorejuvenation. Photodynamic Therapy in Dermatology.SpringerLink. 2011;5–29. doi:10.1007/978-1-4419-1298-5_2.
   Google Scholar
• Dailey HA, Smith A. Differential interaction of porphyrins used in photoradiation therapy with ferrochelatase. Biochem J. 1984;223(2):441–445. doi:10.1042/bj22304416497856
   PubMed Web of Science ®Google Scholar
• Iinuma S, Farshi SS, Ortel B, Hasan T. A mechanistic study of cellular photodestruction with 5-aminolaevulinic acid-induced porphyrin. Br J Cancer. 1994;70(1):21–28. doi:10.1038/bjc.1994.2448018536
   PubMed Web of Science ®Google Scholar
• Photodynamic therapy. UpToDate; 2018.
   Google Scholar
• Touma D, Yaar M, Whitehead S, Konnikov N, Gilchrest BA. A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage. Arch Dermatol. 2004;140(1):33–40. doi:10.1001/archderm.140.1.3314732657
   PubMedGoogle Scholar
• Pariser DM, Houlihan A, Ferdon MB, Berg JE, Group P-AI. Randomized vehicle-controlled study of short drug incubation aminolevulinic acid photodynamic therapy for actinic keratoses of the face or scalp. Dermatol Surg. 2016;42(3):296–304. doi:10.1097/DSS.000000000000063026863596
   PubMed Web of Science ®Google Scholar
• Piacquadio DJ, Chen DM, Farber HF, et al. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials. Arch Dermatol. 2004;140(1):41–46. doi:10.1001/archderm.140.1.4114732659
   PubMedGoogle Scholar
• Kleinpenning MM, Otero ME, van Erp PE, Gerritsen MJ, van de Kerkhof PC. Efficacy of blue light vs. red light in the treatment of psoriasis: a double-blind, randomized comparative study. J Eur Acad Dermatol Venereol. 2012;26(2):219–225. doi:10.1111/j.1468-3083.2011.04039.x21435024
   PubMed Web of Science ®Google Scholar
• Nootheti PK, Goldman MP. Aminolevulinic acid-photodynamic therapy for photorejuvenation. Dermatol Clin. 2007;25(1):35–45. doi:10.1016/j.det.2006.09.01017126740
   PubMed Web of Science ®Google Scholar
• Wan MT, Lin JY. Current evidence and applications of photodynamic therapy in dermatology. Clin Cosmet Investig Dermatol. 2014;7:145–163. doi:10.2147/CCID.S35334
   PubMedGoogle Scholar
• Gandy J, Labadie B, Bierman D, Zachary C. Photodynamic therapy effectively treats actinic keratoses without pre-illumination incubation time. J Drugs Dermatol. 2017;16(3):275–278.28301624
   PubMed Web of Science ®Google Scholar
• Braathen LR, Paredes BE, Saksela O, et al. Short incubation with methyl aminolevulinate for photodynamic therapy of actinic keratoses. J Eur Acad Dermatol Venereol. 2009;23(5):550–555.19415804
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration. Levulan kerastick (Aminolevulinic Acid HCI) topical solution; 1999.
   Google Scholar
• U.S. Food and Drug Administration. AMELUZ (aminolevulinic acid hydrochloride) gel, 10%, for topical use. 1999.
   Google Scholar
• Wiegell SR, Wulf HC, Szeimies RM, et al. Daylight photodynamic therapy for actinic keratosis: an international consensus: international society for photodynamic therapy in dermatology. J Eur Acad Dermatol Venereol. 2012;26(6):673–679. doi:10.1111/j.1468-3083.2011.04386.x22211665
   PubMed Web of Science ®Google Scholar
• Sliney DH. What is light? The visible spectrum and beyond. Eye. 2016;30(2):222–229. doi:10.1038/eye.2015.25226768917
   PubMed Web of Science ®Google Scholar
• Mei X, Wang L, Zhang R, Zhong S. Daylight versus conventional photodynamic therapy for the treatment of actinic keratosis: a meta-analysis of randomized controlled trials. Photodiagnosis Photodyn Ther. 2018;25:23–28.30412779
   PubMed Web of Science ®Google Scholar
• Lacour JP, Ulrich C, Gilaberte Y, et al. Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe. J Eur Acad Dermatol Venereol. 2015;29(12):2342–2348. doi:10.1111/jdv.1322826435363
   PubMed Web of Science ®Google Scholar
• Rubel DM, Spelman L, Murrell DF, et al. Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial. Br J Dermatol. 2014;171(5):1164–1171. doi:10.1111/bjd.1313824861492
   PubMed Web of Science ®Google Scholar
• Wiegell SR, Fabricius S, Stender IM, et al. A randomized, multicentre study of directed daylight exposure times of 1 (1/2)vs. 2 (1/2)h in daylight-mediated photodynamic therapy with methyl aminolaevulinate in patients with multiple thin actinic keratoses of the face and scalp. Br J Dermatol. 2011;164(5):1083–1090. doi:10.1111/j.1365-2133.2011.10209.x21219287
   PubMed Web of Science ®Google Scholar
• Wiegell SR, Haedersdal M, Eriksen P, Wulf HC. Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolaevulinate and home-based daylight exposure: a double-blinded randomized clinical trial. Br J Dermatol. 2009;160(6):1308–1314. doi:10.1111/j.1365-2133.2009.09119.x19416257
   PubMed Web of Science ®Google Scholar
• Wiegell SR, Haedersdal M, Philipsen PA, Eriksen P, Enk CD, Wulf HC. Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study. Br J Dermatol. 2008;158(4):740–746. doi:10.1111/j.1365-2133.2008.08450.x18294318
   PubMed Web of Science ®Google Scholar
• Wiegell SR, Fabricius S, Gniadecka M, et al. Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study. Br J Dermatol. 2012;166(6):1327–1332. doi:10.1111/j.1365-2133.2012.10833.x22250644
   PubMed Web of Science ®Google Scholar
• Schmitz L, Kahl P, Majores M, Bierhoff E, Stockfleth E, Dirschka T. Actinic keratosis: correlation between clinical and histological classification systems. J Eur Acad Dermatol Venereol. 2016;30(8):1303–1307. doi:10.1111/jdv.1362626955898
   PubMed Web of Science ®Google Scholar
• Morton C, Campbell S, Gupta G, et al. Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study. Br J Dermatol. 2006;155(5):1029–1036. doi:10.1111/j.1365-2133.2006.07470.x17034536
   PubMed Web of Science ®Google Scholar
• Szeimies RM, Karrer S, Radakovic-Fijan S, et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study. J Am Acad Dermatol. 2002;47(2):258–262.12140473
   PubMed Web of Science ®Google Scholar
• Tarstedt M, Rosdahl I, Berne B, Svanberg K, Wennberg AM. A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp. Acta Derm Venereol. 2005;85(5):424–428. doi:10.1080/0001555051003288716159735
   PubMed Web of Science ®Google Scholar
• Neittaanmäki-Perttu N, Karppinen TT, Grönroos M, Tani TT, Snellman E. Daylight photodynamic therapy for actinic keratoses: a randomized double-blinded nonsponsored prospective study comparing 5-aminolaevulinic acid nanoemulsion (BF-200) with methyl-5-aminolaevulinate. Br J Dermatol. 2014;171(5):1172–1180. doi:10.1111/bjd.1332625109244
   PubMed Web of Science ®Google Scholar
• Dirschka T, Ekanayake-Bohlig S, Dominicus R, et al. A randomized, intraindividual, non-inferiority, phase III study comparing daylight photodynamic therapy with BF-200 ALA gel and MAL cream for the treatment of actinic keratosis. J Eur Acad Dermatol Venereol. 2019;33(2):288–297. doi:10.1111/jdv.1518530022544
   PubMed Web of Science ®Google Scholar
• Nissen CV, Heerfordt IM, Wiegell SR, Mikkelsen CS, Wulf HC. Pretreatment with 5-fluorouracil cream enhances the efficacy of daylight-mediated photodynamic therapy for actinic keratosis. Acta Derm Venereol. 2017;97(5):617–621. doi:10.2340/00015555-261228093604
   PubMed Web of Science ®Google Scholar
• Seckin D, Cerman AA, Yildiz A, Ergun T. Can topical calcipotriol be a treatment alternative in actinic keratoses? A preliminary report. J Drugs Dermatol. 2009;8(5):451–454.19537367
   PubMed Web of Science ®Google Scholar
• Galimberti GN. Calcipotriol as pretreatment prior to daylight-mediated photodynamic therapy in patients with actinic keratosis: a case series. Photodiagnosis Photodyn Ther. 2018;21:172–175. doi:10.1016/j.pdpdt.2017.11.01929203353
   PubMed Web of Science ®Google Scholar
• Wenande E, Phothong W, Bay C, Karmisholt KE, Haedersdal M, Togsverd-Bo K. Efficacy and safety of daylight photodynamic therapy after tailored pretreatment with ablative fractional laser or microdermabrasion: a randomized, side-by-side, single-blind trial in patients with actinic keratosis and large area field cancerization. Br J Dermatol. 2018;180(4):756–764.30117140
   PubMed Web of Science ®Google Scholar
• Togsverd-Bo K, Lei U, Erlendsson AM, et al. Combination of ablative fractional laser and daylight-mediated photodynamic therapy for actinic keratosis in organ transplant recipients - a randomized controlled trial. Br J Dermatol. 2015;172(2):467–474. doi:10.1111/bjd.1322224975199
   PubMed Web of Science ®Google Scholar
• See JA, Shumack S, Murrell DF, et al. Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in Australia. Australas J Dermatol. 2016;57(3):167–174. doi:10.1111/ajd.1235426033230
   PubMed Web of Science ®Google Scholar
• Philipp-Dormston WG, Sanclemente G, Torezan L, et al. Daylight photodynamic therapy with MAL cream for large-scale photodamaged skin based on the concept of ‘actinic field damage’: recommendations of an international expert group. J Eur Acad Dermatol Venereol. 2016;30(1):8–15. doi:10.1111/jdv.1332726552049
   PubMed Web of Science ®Google Scholar
• Shive ML, Coakley BJ, Bierman DF, et al. Use of 5-aminolevulinic acid and daylight photodynamic therapy for the treatment of actinic keratoses. Dermatol Surg. 2019. doi:10.1097/DSS.0000000000001771
   Web of Science ®Google Scholar